Companies/UK/GSK

GSK plc

Last · LSE£18.30+0.7745 (+4.42%)live · yahoo · 3h ago
Vol 334.6K ≈ 612.48M
Market cap£73.3B4.01B sh
P/E · TTM15.5fwd 9.6 · eps 1.18
Beta0.28vs S&P 500
Div yield3.88%annual · TTM
52w range
£15.92£22.82
Volume334.6Ksession

Issuer

Legal nameGSK plc
HQUnited Kingdom (UK)
ListingLN GSK
ISINGB00BN7SWP63 +4
LEI5493000HZTVUYLO1D793
SectorHealthcare
IndustryPharmaceuticals
CurrencyGBP
Entity registrylei:5493000HZTVUYLO1D793
Org ID03879409
CIK0001131399
Websitewww.gsk.com
LinkedIn
Employees66,841
AddressGSK Plc 79 New Oxford Street WC1A 1DG, London +44 20 8047 5000
Headline financial metrics
Revenue£32.7B
Operating income£7.9B
Net income£5.7B
Free cash flow£6.4B
Operating margin24.3%
Net margin17.5%
Return on equity34.9%
Period2025
Loading chart…

OpenFilings analyst

Our analyst

ANNUAL · 2026-04-26

From latest ANNUAL · 2026-04-26

  • Current Ratio Low

Red flags

  • Current Ratio Low — Current ratio 0.82

Upcoming earnings

1 event
4:30 PM UTC+1
Period
Sep 2026
Est. EPS
$0.50
Est. revenue
8.8B
View upcoming earnings →

Earnings transcripts

2 of 5 recent

Press & signals

3 of 5 recent
  • Satelight

    Fantasy M&A: the recipe for a European champion

  • Satelight

    Biotech deals surge to record as fear of missing out grips Big Pharma

  • Satelight

    GSK in talks to buy cancer biotech Nuvalent for more than $9bn

The rest of this company's wire — with summaries and source links — is part of Pro.

See plans

Documents

FormReporting forFiledFlags
6-K
—2026-10-140
6-K
—2026-10-130
6-K
—2026-10-130
6-K
—2026-10-080
6-K
—2026-10-060
Showing 5 of 189 filings